NCT03739424 (SCENE) is a NA clinical trial of Whole egg powder in Bone Health, sponsored by University of Georgia.

Who is sponsoring NCT03739424?

NCT03739424 is sponsored by University of Georgia.

What drugs are being tested in NCT03739424?

Interventions in NCT03739424: Whole egg powder, Whole milk powder, Gelatin food product.

What condition does NCT03739424 study?

NCT03739424 studies Bone Health, Cognitive Health.

Is NCT03739424 still recruiting?

NCT03739424 is currently completed. Last updated 3 November 2020.

Last reviewed 2020-11-03 · How we verify

NCT03739424: SCENE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Skeletal and Cognitive Effects of Nutrition From Eggs

Completed NA Last updated 3 November 2020

What this trial tests

NA trial testing Whole egg powder in Bone Health in 182 participants. Completed in 11 July 2020.

Timeline

28 April 2018

Primary endpoint
11 July 2020

11 July 2020

Quick facts

Lead sponsor	University of Georgia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	double
Primary purpose	other
Enrollment	182
Start date	28 April 2018
Primary completion	11 July 2020
Estimated completion	11 July 2020
Sites	1 location across United States

Drugs / interventions tested

Whole egg powder
Whole milk powder
Gelatin food product

Conditions studied

Bone Health — all drugs for Bone Health →
Cognitive Health — all drugs for Cognitive Health →

Sponsor

University of Georgia

Who can join

Adults 9 to 13, any sex, with Bone Health or Cognitive Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project is the first egg feeding randomized controlled trial (RCT) in children. The goal of this RCT is to determine if eating formulated whole egg products for 9 months improves bone health and cognitive function in children ages 9-13 years more than children consuming products made of milk powder or gelatin.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The effects of 9 months of formulated whole-egg or milk powder food products as meal or snack replacements on executive function in preadolescents: A randomized, placebo-controlled trial.
O'Connor PJ, Chen X, Coheley LM, Yu M, et al · · 2022 · cited 5× · PMID 36173384 · DOI 10.1093/ajcn/nqac281

Verify or expand the search:

Other trials of Whole egg powder

Trials testing the same drug.

NCT06002438 — Eggs for Gut Health · NA · completed
NCT05206253 — Effectiveness of Egg Versus Whey Protein Powder During Resistance Training · NA · completed
NCT04874688 — Child Health, Agriculture and Integrated Nutrition · NA · completed

Other recruiting trials for Bone Health

Currently open trials in the same condition.

NCT05910606 — Strong Foundations 2.0: A Digitally Delivered Fall Prevention Program. · NA · active not recruiting
NCT05754073 — Oxytocin Effects on Bone in Children With Autism Spectrum Disorder · Phase 2 · recruiting
NCT06547515 — Bone and Muscle Health Following Sleeve Gastrectomy in Men, Premenopausal and Postmenopausal Women · recruiting
NCT04573946 — VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL) · NA · active not recruiting
NCT03455868 — Bone Health After Bariatric Surgery in Patients With Type 2 Diabetes · recruiting

Other University of Georgia trials

Trials by the same sponsor.

NCT07173816 — Optimizing PrEP Uptake for African American Women in the South by Empowering Women to Make Informed HIV Prevention and S · NA · not yet recruiting
NCT06799702 — Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inje · NA · not yet recruiting
NCT06987526 — Renewed Recovery: a Pilot Test of a Web-Based Mindfulness-Based Relapse Prevention Continuing Care Intervention for Alco · NA · recruiting
NCT06193343 — Steps Towards Osteoarthritis Prevention · NA · recruiting
NCT06424756 — Effects of an Antioxidant Supplement on Blood Vessel Health · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03739424 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Georgia
Last refreshed: 3 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03739424.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing